IGF1 and type 2 diabetes mellitus: A strength of the present study is that it was done in healthy young people, with normal glucose tolerance, eliminating skewed results because of, ie, lowered GLP‐1 sensitivity (as seen in patients with type 2 diabetes).35 Another strength is that the bone remodeling process was examined thoroughly by analyzing a range of different markers and hormones (CTX, OPG, PTH, OC, P1NP, and IGF‐1).